Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 2
2024 pubmed 2 citations

LL-37 regulates odontogenic differentiation of dental pulp stem cells in an inflammatory microenvironment.

Ma. Yunfeng Y; Liu. Xinyuan X; Dai. Ruoxi R; Li. Quanli Q; Cao. Chris Ying CY

Key Findings

  • LL‑37 increases migration of dental pulp stem cells in an inflammatory setting
  • LL‑37 lowers expression of inflammatory and aging‑related genes (TNF‑α, IL‑1β, IL‑6, P21, P38, P53)
  • LL‑37 enhances odontogenic differentiation, raising ALP activity, calcium nodule formation, and dentin‑related genes (DMP1, DSPP, BSP)

Practical Outcomes

  • LL‑37 could become a topical or injectable therapy to aid pulp regeneration after injury or infection, but no human dosing or safety data exist yet. For now, it’s a promising concept for future dental bio‑hacking, not a ready‑to‑use protocol.

Summary

The study shows that the natural peptide LL‑37 can help dental pulp stem cells move to damaged areas, calm down inflammation, and turn into tooth‑building cells even when inflammation is present. This points to LL‑37 as a possible future treatment for inflamed dental pulp, but it’s still early‑stage lab work.

Abstract

Inflammation often causes irreversible damage to dental pulp tissue. Dental pulp stem cells (DPSCs), which have multidirectional differentiation ability, play critical roles in the repair and regeneration of pulp tissue. However, the presence of proinflammatory factors can affect DPSCs proliferation, differentiation, migration, and other functions. LL-37 is a natural cationic polypeptide that inhibits lipopolysaccharide (LPS) activity, enhances cytokine production, and promotes the migration of stem cells. However, the potential of LL-37 in regenerative endodontics remains unknown. This study aimed to investigate the regulatory role of LL-37 in promoting the migration and odontogenic differentiation of DPSCs within an inflammatory microenvironment. These findings establish an experimental foundation for the regenerative treatment of pulpitis and provide a scientific basis for its clinical application. DPSCs were isolated via enzyme digestion combined with the tissue block adhesion method and identified via flow cytometry. The impact of LL-37 on the proliferation of DPSCs was evaluated via a CCK-8 assay. The recruitment of DPSCs was assessed through a transwell assay. The mRNA expression levels of inflammatory and aging-related genes were assessed via reverse transcription‒polymerase chain reaction (RT‒PCR), western blotting, and enzyme‒linked immunosorbent assay (ELISA). The odontogenic differentiation of DPSCs was assessed through alkaline phosphatase (ALP) staining, alizarin red staining, and RT‒PCR analysis. LL-37 has the potential to enhance the migration of DPSCs. In an inflammatory microenvironment, LL-37 can suppress the expression of genes associated with inflammation and aging, such as TNF-α, IL-1β, IL-6, P21, P38 and P53. Moreover, it promotes odontogenic differentiation in DPSCs by increasing ALP activity, increasing calcium nodule formation, and increasing the expression of dentin-related genes such as DMP1, DSPP and BSP. These findings suggest that the polypeptide LL-37 facilitates the migration of DPSCs and plays a crucial role in resolving inflammation and promoting cell differentiation within an inflammatory microenvironment. Consequently, LL-37 has promising potential as an innovative therapeutic approach for managing inflammatory dental pulp conditions.

Study Information

Provider

pubmed

Year

2024

Date

2024-12-18T00:00:00.000Z

DOI

10.1186/s13287-024-04075-7

Citations

2

References

69